Finance

Beta
Lists
OCGN:NASDAQ
Ocugen Inc
$1.50
+9.49%
(+0.13) 1D
$1.51
+0.66% (+0.0099)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCGN...
Open
$1.36
High
$1.52
Low
$1.36
Mkt. cap
507.78M
Avg. vol.
6.16M
Volume
57.05M
52-wk high
$2.72
52-wk low
$0.90
EPS
-$0.23
Beta
2.19
Shares outstanding
338.52M
No. of employees
116
Open
$1.36
High
$1.52
Low
$1.36
Mkt. cap
507.78M
Avg. vol.
6.16M
Volume
57.05M
52-wk high
$2.72
52-wk low
$0.90
EPS
-$0.23
Beta
2.19
Shares outstanding
338.52M
No. of employees
116
News stories
From sources across the web
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteocugen.com
Analyst ratings
Based on 6 analysts giving stock ratings to OCGN in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for OCGN in the last 3 months.
Highest
Current $1.50
$12.00 (+700.00%)
Average
$9.67 (+544.67%)
Lowest
$7.00 (+366.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$11.00
+633.3%
05/27/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$10.00
+566.7%
05/11/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$8.00
+433.3%
05/06/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$7.00
+366.7%
05/07/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$12.00
+700%
05/06/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$10.00
+566.7%
05/06/2026
Elemer Piros
Lucid Capital
Buy
Maintained
$22.00
+1,366.7%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.37M
1.75M
-193.00K
1.53M
Cost of goods sold
8.40M
11.15M
10.67M
11.26M
Cost of revenue
8.40M
11.15M
10.67M
11.26M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.77M
8.23M
6.13M
8.12M
Operating expense
6.77M
9.55M
4.99M
8.12M
Total operating expenses
15.17M
20.70M
15.66M
19.37M
Operating income
-13.80M
-18.94M
-15.85M
-17.84M
Other non operating income
114.00K
-
-664.00K
-150.00K
EBT including unusual items
-14.74M
-20.05M
-17.71M
-19.18M
EBT excluding unusual items
-14.74M
-20.05M
-17.71M
-19.18M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
1.32M
-1.14M
-
Net income
-14.74M
-20.05M
-17.71M
-19.18M
Net profit margin
-1,073.49%
-1,144.46%
9,174.09%
-1,250.95%
Earnings per share
-0.05
-0.07
-0.06
-0.06
Interest and investment income
200.00K
207.00K
144.00K
132.00K
Interest expense
-1.26M
-1.31M
-1.33M
-1.32M
Net interest expenses
-1.06M
-1.11M
-1.19M
-1.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.87M
-17.99M
-15.26M
-17.25M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of OCGN
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer